Volitionrx (VNRX) Receivables - Other (2018 - 2019)
Volitionrx posted quarterly Receivables - Other of $1.0 million for Q3 2019, little changed year-on-year from $1.0 million in Q3 2018, and little changed on a QoQ basis from $1.0 million in Q4 2018.
Volitionrx (VNRX) has 2 years of Receivables - Other data on file, last reported at $1.0 million in Q3 2019.
- For the quarter ending Q3 2019, Receivables - Other changed 0.0% year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2019 stood at $1.0 million (changed 0.0% YoY), and the FY2018 full-year result was $1.0 million, changed N/A from the prior year.
- Receivables - Other for Q3 2019 stood at $1.0 million, roughly flat from $1.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.0 million in Q3 2018 and bottomed at $1.0 million in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 1.05 Mn |
| Sep 30, 2019 | 1.05 Mn |
| Dec 31, 2018 | 1.05 Mn |
| Dec 31, 2018 | 1.05 Mn |
| Sep 30, 2018 | 1.05 Mn |
| Sep 30, 2018 | 1.05 Mn |